Corporate Engagement Office appoints associate vice president of technology commercialization
Kevin Taylor has joined The Ohio State University as associate vice president of technology commercialization in the Corporate Engagement Office. In this role, he leads Ohio State’s technology transfer team and works with researchers across the university to translate their innovations into commercial opportunities that will positively impact people’s lives and benefit the global community.
Taylor’s career has spanned all aspects of commercialization from discovery and innovation through new company formation, launch, and global P&L management. He has a diverse background across healthcare, engineering and national security applications and is passionate about transforming innovations into meaningful products and services. Most recently, Taylor was vice president for healthcare at Beyond Limits, a growth-stage artificial intelligence company based on technology licensed out of Caltech. There, he led strategy, marketing and business development for the healthcare services business unit.
Prior to that, he served in several roles at Cardinal Health, including vice president for global market development and director of innovation for patient care. While at Cardinal, he led upstream marketing and global product management for the company’s medical products portfolio, driving the commercialization strategy for 7,000 products sold in 35 countries. Taylor started his career as a researcher at Battelle, where his responsibilities grew to include research and development investment, patent portfolio management, licensing, business development, sales and marketing and more. Kevin also has experience in venture capital for early-stage companies.
Taylor is a proud Buckeye, earning his Bachelor of Science and Master of Science degrees in Electrical Engineering at Ohio State. He also earned his Master of Science in Technology and Innovation Management with distinction from the University of Sussex (England). He is a member of the Licensing Executives Society (LES), a patent holder and a recipient of two R&D 100 Awards.
Taylor comes to Ohio State at a time of upward momentum in technology commercialization. The university set a record high in technology commercialization licensing income in 2018 – ending the fiscal year at more than $7.9 million, more than double the previous year’s income. Ohio State startups are thriving as well. The portfolio of active startups created from Ohio State research is now at 85, with 18 new startups created in FY18.